Pfanstiehl

High-Purity, Low-Endotoxin Carbohydrates, Parenteral Grade Excipients and Highly Potent APIs

Pfanstiehl Will Attend PepTalk: the Protein Science Week

Pfanstiehl will be attending PepTalk: the Protein Science Week from 19-23 January 2015 in San...

Pfanstiehl Will Attend PepTalk: the Protein Science Week

Pfanstiehl Launches cGMP-produced, Parenteral Grade Mannitol for Pharmaceutical Formulations

Pfanstiehl has announced the launch of a new high-purity, low-endotoxin, Mannitol, which is manufactured in the US under strict current good manufacturing practices (cGMP) and ICH Q7...

Pfanstiehl Launches cGMP-produced, Parenteral Grade Mannitol for Pharmaceutical Formulations

Pfanstiehl Launches cGMP-produced Mannose for Cell Culture Media Optimization and Glycoprotein Biosynthesis

Pfanstiehl has announced the launch of cGMP-produced, high purity Mannose (USP/NF, EP), manufactured in the US under ICH Q7 compliant conditions....

Pfanstiehl Launches cGMP-produced Mannose for Cell Culture Media Optimization and Glycoprotein Biosynthesis

Pfanstiehl Gearing Up for Potent API Expansion

Pfanstiehl is aggressively investing in its potent API contract manufacturing capabilities at its US-based cGMP facility located north of Chicago, US....

Pfanstiehl Gearing Up for Potent API Expansion

Pfanstiehl Launches cGMP-produced, Non-Animal-Derived Galactose for Optimizing Cell Culture Media

Pfanstiehl just announced the launch of its new high purity, low endotoxin, non-animal-derived Galactose (USP/NF, EP), manufactured in the US under strict cGMP, ICH Q7-compliant conditions....

Pfanstiehl Launches cGMP-produced, Non-Animal-Derived Galactose for Optimizing Cell Culture Media